TUMOR INFILTRATING LYMPHOCYTES
Clinical trials for TUMOR INFILTRATING LYMPHOCYTES explained in plain language.
Never miss a new study
Get alerted when new TUMOR INFILTRATING LYMPHOCYTES trials appear
Sign up with your email to follow new studies for TUMOR INFILTRATING LYMPHOCYTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could your own tumor cells beat cancer? new trial launches
Disease control Recruiting nowThis early-stage study tests a treatment using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), to fight advanced solid tumors. About 30 adults who have not responded to standard treatments will receive these cells along with chemotherapy. The main goal…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:30 UTC
-
Engineered immune cells take on pancreatic cancer in first human test
Disease control Recruiting nowThis early-phase study tests a new treatment called GC203 TIL for people with pancreatic cancer that has not responded to standard therapies. The treatment uses a patient's own immune cells, which are collected from their tumor, genetically modified to fight cancer better, and th…
Matched conditions: TUMOR INFILTRATING LYMPHOCYTES
Phase: EARLY_PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:29 UTC